Phthalate exposure and childrens neurodevelopment: A systematic review

Maede Ejaredar1, Elias C Nyanza1, Kayla Ten Eycke2

  • 1Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.

Insights

Prenatal exposure to phthalates is linked to negative impacts on children's neurodevelopment, including lower IQ and attention issues. This systematic review highlights the need for further research on phthalate metabolites and child development to inform health policies.

Area of Science:

  • Environmental Health
  • Neuroscience
  • Pediatrics

Background:

  • Observational studies indicate prenatal phthalate exposure may impact child neurodevelopment.
  • Phthalates are common chemicals found in many consumer products.

Purpose of the Study:

  • To systematically review existing literature on the association between urinary phthalate concentrations and children's neurodevelopment.
  • To synthesize findings on phthalate exposure and cognitive and behavioral outcomes in children.

Main Methods:

  • Comprehensive literature search of multiple electronic databases and conference abstracts up to February 2014.
  • Inclusion of original studies examining prenatal or childhood urinary phthalate metabolites and neurodevelopmental outcomes (0-12 years).
  • Data extraction and screening conducted by two independent reviewers.

Main Results:

  • Eleven original articles met the inclusion criteria after screening 2804 abstracts.
  • The reviewed studies consistently reported associations between prenatal phthalate exposure and adverse neurodevelopmental outcomes.

Conclusions:

  • A systematic review supports the link between prenatal phthalate exposure and adverse cognitive and behavioral outcomes in children.
  • Outcomes include lower IQ, attention deficits, hyperactivity, and impaired social communication.
  • Further research is needed to identify specific phthalate metabolite associations and inform mitigation strategies and health policy.
Abstract

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.1K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.7K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
146
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
664